|
|
||||||||
The Journal of Immunology, Vol 155, Issue 2 609-618, Copyright © 1995 by American Association of Immunologists
ARTICLES |
S Rich, M Seelig, HM Lee and J Lin
Department of Microbiology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.
Transforming growth factor beta (TGF-beta) exhibits diverse effects on growth and differentiation of a wide range of cell types. In the immune system, TGF-beta 1 is a potent inhibitor of T cell proliferation and certain T cell effector functions. However, TGF-beta 1 also enhances growth of T cells, predominantly of naive phenotype, and induces their expression of selected cytokines. We have previously demonstrated that TGF-beta 1 costimulates growth of highly purified murine CD8+ T cells activated by immobilized anti-CD3 Ab. TGF-beta 1-costimulated CD8+ T cells rapidly express a memory phenotype, lose lytic function, and express a mixed cytokine pattern with IL-2, IFN-gamma, and appreciable IL-10, as well as TGF-beta 1. The present work examines the possibility that TGF-beta 1 similarly costimulates response of murine CD8+ T cells to the microbial superantigen staphylococcal enterotoxin B (SEB) and characterizes their effector and regulatory functions. TGF-beta 1 significantly enhances CD8+ T cell proliferation to SEB in the presence of MHC class II-positive APC and TGF-beta 1-primed CD8+ T cells are enriched for SEB-reactive V beta 8+ TCR expression. TGF-beta 1 priming also up-regulates a memory-like CD45RBlowCD44highMEL-14low phenotype. TGF-beta 1 priming inhibits development of SEB-specific lytic effector function by more than 90%. However, TGF-beta 1-primed CD8+ effector T cells express elevated levels of IL-10 and TGF-beta 1, variable IFN- gamma, and undetectable IL-4. Additionally, they exhibit growth inhibitory effector function of SEB-induced proliferation of other CD4+ and CD8+ T cells. Growth inhibition by TGF-beta 1-primed CD8+ T cells is reversed in part by anti-IL-10 Ab. Thus, in the context of SEB response, TGF-beta 1 promotes the outgrowth and induces the effector function of CD8+ T cells that have the capacity to impair T cell clonal growth.
This article has been cited by other articles:
![]() |
M. Elrefaei, C. A. R. Baker, N. G. Jones, D. R. Bangsberg, and H. Cao Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated with Increased PD-1 Expression on Effector CD8+ T Cells J. Immunol., June 1, 2008; 180(11): 7757 - 7763. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Menoret, L. M. Myers, S.-J. Lee, R. S. Mittler, R. J. Rossi, and A. T. Vella TGFbeta Protein Processing and Activity through TCR Triggering of Primary CD8+ T Regulatory Cells J. Immunol., November 1, 2006; 177(9): 6091 - 6097. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Kapp, K. Honjo, L. M. Kapp, X. y. Xu, A. Cozier, and R. P. Bucy TCR transgenic CD8+ T cells activated in the presence of TGF{beta} express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection Int. Immunol., November 1, 2006; 18(11): 1549 - 1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Murano, X. Xiong, N. Murano, J. L. Salzer, J. J. Lafaille, and V. K. Tsiagbe Latent TGF-{beta}1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis J. Leukoc. Biol., January 1, 2006; 79(1): 140 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Horwitz, S. G. Zheng, and J. D. Gray The role of the combination of IL-2 and TGF-{beta} or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets J. Leukoc. Biol., October 1, 2003; 74(4): 471 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Kao, Y. Gong, C.-M. Chen, Q.-D. Zheng, and J.-J. Chen Tumor-Derived TGF-{beta} Reduces the Efficacy of Dendritic Cell/Tumor Fusion Vaccine J. Immunol., April 1, 2003; 170(7): 3806 - 3811. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-C. Fan and R. R. Singh Vaccination with Minigenes Encoding VH-derived Major Histocompatibility Complex Class I-binding Epitopes Activates Cytotoxic T Cells that Ablate Autoantibody-producing B Cells and Inhibit Lupus J. Exp. Med., September 16, 2002; 196(6): 731 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Singh, F. M. Ebling, D. A. Albuquerque, V. Saxena, V. Kumar, E. H. Giannini, T. N. Marion, F. D. Finkelman, and B. H. Hahn Induction of Autoantibody Production Is Limited in Nonautoimmune Mice J. Immunol., July 1, 2002; 169(1): 587 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Noel, S. Florquin, M. Goldman, and M. Y. Braun Chronic exposure to superantigen induces regulatory CD4+ T cells with IL-10-mediated suppressive activity Int. Immunol., April 1, 2001; 13(4): 431 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Akdis, H.-U. Simon, L. Weigl, O. Kreyden, K. Blaser, and C. A. Akdis Skin Homing (Cutaneous Lymphocyte-Associated Antigen-Positive) CD8+ T Cells Respond to Superantigen and Contribute to Eosinophilia and IgE Production in Atopic Dermatitis J. Immunol., July 1, 1999; 163(1): 466 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Galdiero, A. Marcatili, G. Cipollaro de l'ero, I. Nuzzo, C. Bentivoglio, M. Galdiero, and C. R. Carratelli Effect of Transforming Growth Factor beta on Experimental Salmonella typhimurium Infection in Mice Infect. Immun., March 1, 1999; 67(3): 1432 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Z. Chen, G. M. Hochwald, C. Huang, G. Dakin, H. Tao, C. Cheng, W. J. Simmons, G. Dranoff, and G. J. Thorbecke Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta 1 PNAS, October 13, 1998; 95(21): 12516 - 12521. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |